TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Redo Biosolutions AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
122,485
|
148,040
|
131,408 |
| Financial expenses |
265
|
2
|
7 |
| Earnings before taxes |
2,713
|
25,958
|
26,060 |
| EBITDA |
5,871
|
30,060
|
29,090 |
| Total assets |
245,541
|
108,905
|
83,338 |
| Current assets |
168,626
|
79,307
|
49,861 |
| Current liabilities |
136,532
|
39,058
|
35,339 |
| Equity capital |
107,412
|
68,418
|
47,999 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
5
|
4
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.7%
|
62.8%
|
57.6% |
| Turnover per employee |
24,497
|
37,010
|
43,803 |
| Profit as a percentage of turnover |
2.2%
|
17.5%
|
19.8% |
| Return on assets (ROA) |
1.2%
|
23.8%
|
31.3% |
| Current ratio |
123.5%
|
203.0%
|
141.1% |
| Return on equity (ROE) |
2.5%
|
37.9%
|
54.3% |
| Change turnover |
-25,555
|
16,632
|
69,582 |
| Change turnover % |
-17%
|
13%
|
113% |
| Chg. No. of employees |
1
|
1
|
3 |
| Chg. No. of employees % |
25%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.